Quick Takeaways
- Quan Anh Vu has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $217,134.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Quan Anh Vu and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | Cfo/Cbo | $108,355 | 06 Mar 2023 | ||
| MNPR | Monopar Therapeutics | Chief Financial Officer | $104,925 | +$104,925 | +100% | 26 Dec 2025 |
| FRMM | 180 Life Sciences Corp. | COO / Chief Business Officer | $3,854 | 16 Dec 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|